Head, Corporate Strategy & Innovation and Licensing @ Astellas Americas
Bob Chib was appointed the head of corporate strategy & innovation and licensing & acquisitions for Astellas in April 1, 2016. In this role, Bob is responsible for leading the overall strategic direction and growth plan of the Americas Operations (Canada, US, Latin Americas) including Corporate Strategy, Corporate Planning, Innovation Management, Business Model Evolution, Digital Health and Licensing & Alliances. Previously, Bob served as the head of the Strategic Account Business Unit, an incubator for a revolutionary new commercial model that Astellas is deploying across the Americas.
Bob’s 20-year career spans a variety of diverse disciplines within the health care industry, including clinical research, sales, marketing, new product planning, managed markets, business development, corporate planning and global commercial operations.
Bob holds an Executive MBA from the Northwestern University Kellogg School of Management and a Bachelor of Science in Biological Studies from Rutgers University.